ORAI1 Gene

ORAI1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ORAI1 — Calcium Release-Activated Calcium Channel Protein 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ORAI1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Calcium Release-Activated Calcium Channel Protein 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>12q24.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/84876" target="_blank">84876</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000182578" target="_blank">ENSG00000182578</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/610277" target="_blank">610277</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprotkb/Q8WTG4/entry" target="_blank">Q8WTG4</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>329 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~33 kDa</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Immunodeficiency, Stroke</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>T cells, Mast cells, Neurons, Astrocytes, Platelets</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:

ORAI1 Gene

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">ORAI1 — Calcium Release-Activated Calcium Channel Protein 1</th>
</tr>
<tr>
<td class="label">Symbol</td>
<td><strong>ORAI1</strong></td>
</tr>
<tr>
<td class="label">Full Name</td>
<td>Calcium Release-Activated Calcium Channel Protein 1</td>
</tr>
<tr>
<td class="label">Chromosome</td>
<td>12q24.31</td>
</tr>
<tr>
<td class="label">NCBI Gene</td>
<td><a href="https://www.ncbi.nlm.nih.gov/gene/84876" target="_blank">84876</a></td>
</tr>
<tr>
<td class="label">Ensembl</td>
<td><a href="https://ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000182578" target="_blank">ENSG00000182578</a></td>
</tr>
<tr>
<td class="label">OMIM</td>
<td><a href="https://www.omim.org/entry/610277" target="_blank">610277</a></td>
</tr>
<tr>
<td class="label">UniProt</td>
<td><a href="https://www.uniprot.org/uniprotkb/Q8WTG4/entry" target="_blank">Q8WTG4</a></td>
</tr>
<tr>
<td class="label">Protein Length</td>
<td>329 amino acids</td>
</tr>
<tr>
<td class="label">Molecular Weight</td>
<td>~33 kDa</td>
</tr>
<tr>
<td class="label">Diseases</td>
<td>[Alzheimer's Disease](/diseases/alzheimers), [Parkinson's Disease](/diseases/parkinsons-disease), Immunodeficiency, Stroke</td>
</tr>
<tr>
<td class="label">Expression</td>
<td>T cells, Mast cells, Neurons, Astrocytes, Platelets</td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">29 edges</a></td>
</tr>
</table>

ORAI1 — Calcium Release-Activated Calcium Channel Protein 1

Overview

ORAI1 encodes the pore-forming subunit of the calcium release-activated calcium (CRAC) channel, the primary pathway for store-operated calcium entry (SOCE) in eukaryotic cells. This channel represents the critical effector of the store-operated signaling pathway, responding to depletion of endoplasmic reticulum (ER) calcium stores by mediating rapid calcium influx across the plasma membrane. First identified through studies of patients with severe combined immunodeficiency (SCID), ORAI1 has since been recognized as a crucial regulator of calcium signaling in numerous cell types, including [neurons](/entities/neurons), [astrocytes](/cell-types/astrocytes), and immune cells["@stathopulos2019"].

Introduction

The discovery of ORAI1 represents one of the most significant breakthroughs in calcium signaling research of the past two decades. Before its identification, the molecular identity of the CRAC channel had remained elusive for over 30 years despite extensive research efforts. The protein takes its name from the Greek word "ora" (mouth), reflecting its function as the channel that literally forms the mouth-like opening through which calcium enters the cell following ER calcium depletion[@prakriya2020].

In neurons, CRAC channels formed by ORAI1 (in combination with ORAI2 and ORAI3) play critical roles in synaptic plasticity, gene expression, and cellular survival. The close functional relationship between ORAI1 and its activator [STIM1](/genes/stim1) creates a sophisticated calcium signaling system that responds dynamically to neuronal activity and pathological challenges.

Gene Structure and Expression

Genomic Organization

The ORAI1 gene is located on chromosome 12q24.31 and contains 4 coding exons. Alternative splicing produces multiple transcript variants with differential expression patterns. The promoter contains binding sites for NFAT, AP-1, and other activity-dependent transcription factors, enabling rapid transcriptional regulation in response to calcium signaling.

Tissue Distribution

ORAI1 exhibits broad but distinct expression patterns:

• Immune system: Highest expression in T lymphocytes, natural killer cells, and mast cells
• Brain: Neurons and astrocytes in cortex, hippocampus, and cerebellum
• Cardiovascular: Endothelial cells, vascular smooth muscle
• Other tissues: Pancreatic beta cells, platelets, fibroblasts

Protein Structure and Function

Topology

ORAI1 is a small transmembrane protein with unique structural features:

• Four transmembrane segments: Forming a compact channel pore
• N-terminal and C-terminal cytoplasmic domains: Involved in channel regulation and interaction with STIM
• Pore loop: Forms the selectivity filter and ion conduction pathway
• Tetameric assembly: Four ORAI1 subunits assemble to form a functional channel

Store-Operated Activation Mechanism

The activation of ORAI1 follows a precisely orchestrated sequence:

This mechanism provides highly localized Ca2+ signals that precisely match cellular demands.

Permeation Properties

ORAI1 channels exhibit distinctive biophysical properties:

• High selectivity: Preferential permeability to Ca2+ over Na+ (Pc/PN ~ 1000)
• Low conductance: Small single-channel conductance (~10 pS)
• Rapid kinetics: Fast activation and deactivation rates
• Voltage dependence: Mild inward rectification

Role in Neurodegeneration

Alzheimer's Disease

CRAC channels contribute to AD pathophysiology through multiple mechanisms:

• Amyloid-β effects: Aβ oligomers promote ER stress and store depletion, activating SOCE
• Calcium dysregulation: Chronic ORAI1 overactivation leads to calcium overload
• Synaptic dysfunction: Altered SOCE impairs synaptic plasticity and memory formation
• Neuronal death: Excessive calcium influx through ORAI1 can trigger apoptosis
• Therapeutic targeting: ORAI1 inhibitors show promise in AD models[@korkuat2020]

Parkinson's Disease

In dopaminergic neurons, ORAI1 plays complex roles:

• ER stress: Alpha-synuclein aggregation promotes calcium store depletion
• Calcium dysregulation: Excessive SOCE contributes to neuronal vulnerability
• Mitochondrial dysfunction: ORAI1-mediated calcium influx affects mitochondrial health
• Neuroinflammation: ORAI1 in microglia promotes inflammatory responses
• Therapeutic potential: ORAI1 modulators may provide neuroprotection[@wang2019]

Stroke and Ischemia

Following cerebral ischemia, ORAI1 contributes to secondary neuronal injury:

• Store depletion: Energy failure leads to ER calcium depletion
• Pathological activation: Excessive SOCE promotes calcium overload
• Excitotoxicity: ORAI1 activation synergizes with glutamate toxicity
• Neuroprotection: ORAI1 blockers reduce infarct size in experimental models

Neuroinflammation

ORAI1 plays a central role in neuroinflammatory processes:

• Microglial activation: ORAI1 is required for inflammatory cytokine production
• T cell infiltration: SOCE in peripheral immune cells contributes to CNS inflammation
• Astrocyte responses: ORAI1-mediated signaling in astrocytes modulates neuroinflammation

Therapeutic Implications

Current Approaches

| Strategy | Compound | Status | Mechanism |
|----------|----------|--------|-----------|
| ORAI1 inhibitors | YM-58483 | Preclinical | Block CRAC channel pore |
| STIM1-ORAI1 disruptors | Synta66 | Research | Prevent coupling |
| Gene therapy | siRNA | Preclinical | Reduce ORAI1 expression |

Challenges

Future Directions

• Isoform-selective inhibitors: Targeting specific ORAI isoforms
• Cell-type specific delivery: CNS versus immune system targeting
• Activity-dependent modulators: Compounds that modulate rather than block SOCE

Interactome

ORAI1 interacts with:

• STIM proteins: STIM1, STIM2 (direct activation)
• Calmodulin: Calcium-dependent regulation
• CRAC regulators: ORAI2, ORAI3 (hetero-oligomerization)
• Signaling proteins: PKC, calcineurin
• Cytoskeletal elements: Actin, tubulin

Animal Models

Transgenic Models

• ORAI1 knockout mice: Viable but impaired immune function
• Conditional knockouts: Neuron-specific and immune cell-specific deletion
• Mutant models: Human SCID mutations introduced into mice

Phenotypic Characteristics

• Severe combined immunodeficiency
• Impaired T cell activation and proliferation
• Defective mast cell degranulation
• Altered neuronal plasticity in conditional knockouts

Research Directions

See Also

• [Calcium Signaling](/mechanisms/calcium-signaling)
• [Store-Operated Calcium Entry](/mechanisms/store-operated-calcium-entry)
• [STIM1](/genes/stim1)
• [STIM2](/genes/stim2)
• [Alzheimer's Disease](/diseases/alzheimers-disease)
• [Parkinson's Disease](/diseases/parkinsons-disease)
• [Neuroinflammation](/mechanisms/neuroinflammation)
• [NCX1](/genes/ncx1)

References

Pathway Diagram

The following diagram shows the key molecular relationships involving ORAI1 Gene discovered through SciDEX knowledge graph analysis: